Gaucher Disease Medications
Definition of Gaucher Disease: An inherited deficiency of an enzyme (-glucosidase) which results in the buildup of a toxic substance (glucosylceramide) in different parts of the body, such as the spleen, liver, and bones.
Drugs (by generic name) associated with Gaucher Disease
The following drugs and medications are in some way related to, or used in the treatment of Gaucher Disease. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
| Drug Name |
Reviews | Ratings |
||
|---|---|---|---|---|
| miglustat systemic (Pro, More...) | 0 review(s) | Not rated - Be the first | ||
| imiglucerase systemic (Pro, More...) | 0 review(s) | Not rated - Be the first | ||
| alglucerase systemic (Pro, More...) | 0 review(s) | Not rated - Be the first | ||
See also...
Gaucher Disease Medications in the Pipeline
- November 4, 2009 - FDA Grants Priority Review for Shire's velaglucerase alfa for Type 1 Gaucher Disease
- September 2, 2009 - Shire Completes Submission of NDA for Velaglucerase Alfa for Type 1 Gaucher Disease and Reports Positive Results for Remaining Two Phase III Trials
- July 7, 2009 - Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
- July 14, 2009 - Protalix Holds Pre-NDA Meeting with FDA for prGCD
Latest Gaucher Disease Blog Post
Study of Genzyme Oral Compound for Gaucher Disease Meets Primary Endpoint
Phase 3 Trials Planned to Begin Mid-2009
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corp. (NASDAQ: GENZ) today reported that the Phase 2 clinical trial of its investigational oral therapy Genz-112638 for Gaucher disease type 1 met its primary endpoint....
View all Gaucher Disease blog posts.
Gaucher Disease Support Group Questions
Ask a Question about Gaucher Disease:
Learn more about Gaucher Disease
Medical encyclopedia results for:
